ASIA VETS HOLDINGS LTD. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.026 SGD | -13.33% |
|
-51.85% | -10.34% |
| 02-22 | Asia Vets Widens H2 Attributable Loss Amid Increased Spending | MT |
| 02-21 | Asia Vets Holdings Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| Sales 2022 | 2.42M 1.78M 142M | Sales 2023 | 2.33M 1.71M 137M | Capitalization | 4.24M 3.11M 249M |
|---|---|---|---|---|---|
| Net income 2022 | - 0 0 | Net income 2023 | - 0 0 | EV / Sales 2022 | -1.03 x |
| Net cash position 2022 | 9.79M 7.19M 576M | Net cash position 2023 | 8.86M 6.5M 521M | EV / Sales 2023 | -1.99 x |
| P/E ratio 2022 |
-9.53
x | P/E ratio 2023 |
-5.69
x | Employees | 21 |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 33.99% |
More Fundamentals
* Assessed data
More news
More press releases
| 1 day | -13.33% | ||
| 1 week | -51.85% | ||
| Current month | -25.71% | ||
| 1 month | -23.53% | ||
| 3 months | -21.21% | ||
| 6 months | -59.38% | ||
| Current year | -10.34% |
1 week
0.03
0.05
1 month
0.030.05
Current year
0.020.06
1 year
0.020.07
3 years
0.020.10
5 years
0.020.18
10 years
0.020.28
| Managers | Title | Age | Since |
|---|---|---|---|
Tong Guan Tan
CEO | Chief Executive Officer | 61 | 16/02/10 |
Ru Xue
DFI | Director of Finance/CFO | 49 | 19/07/16 |
Sheng Jun Gong
COO | Chief Operating Officer | 44 | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Song Kok Tan
BRD | Director/Board Member | 59 | 31/12/19 |
Tong Guan Tan
CEO | Chief Executive Officer | 61 | 16/02/10 |
Teck Kim Seah
BRD | Director/Board Member | 70 | 24/04/19 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24/04/24 | 0.026 | -13.33% | 6,200 |
| 23/04/24 | 0.03 | -41.18% | 300 |
| 22/04/24 | 0.051 | -5.56% | 300 |
Delayed Quote Singapore S.E., April 24, 2024 at 09:10 am
More quotes
Asia Vets Holdings Ltd., through its subsidiary, AVH Animal Ark Pte. Ltd., provides veterinary care and clinical services to small animals in Singapore. The Company operates two veterinary clinics which provide a full range of general veterinary services including medical, surgical and dental care for small animals including dogs, cats, rabbits and other pocket pets. The Company is providing its patients with advanced diagnostic and the latest in surgical procedures, such as key-hole surgery. It also provides complementary remedies and treatments, such as acupuncture and traditional Chinese medicine at its clinics. In addition to surgical oncology and chemotherapy, it also utilizes natural killer cell and stem cell therapies in the treatment of cancers. Its services include acupuncture, allergy testing and treatment, day hospitalization, dental services, diagnostic imaging, laboratory services and general medicine, pocket pets, vaccinations and export health certification, and other.
Calendar
06/08/2024
- Q2 2024 Earnings Release (Projected)
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -10.34% | 2.79M | |
| -33.57% | 130M |
- Stock Market
- Equities
- 5RE Stock
